Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of γ-aminobutyric acid type A receptors

The steroids allopregnanolone and allotetrahydrodeoxycorticosterone (3alpha,5alpha-THDOC) are positive allosteric modulators of GABA(A) receptors, generated by the reduction of 5alpha-dihydroprogesterone (5alpha-DHP) and 5alpha-DHDOC, respectively, under the catalysis of human type 3 3alpha-hydroxysteroid dehydrogenase (HSD). However, brain enzymes catalyzing the conversion of such tetrahydrosteroids back to the corresponding 5alpha-dihydrosteroids remain to be identified. Characterization of human type 10 17beta-HSD provides a new insight into its importance for the oxidation of steroid modulators of GABA(A) receptors. The apparent catalytic efficiency (k(cat)/K(m)) of this enzyme for the oxidation of allopregnanolone and 3alpha,5alpha-THDOC are 432 and 1381 min(-1) mM(-1), respectively. This enzyme has negligible 3-ketosteroid reductase activity for 5alpha-DHP and 5alpha-DHDOC even in an acidic environment. Immunoreactivity against 17beta-HSD10 was found in a number of neuronal populations. Taken together, evidence suggests that 17beta-HSD10 is the brain enzyme capable of catalyzing the oxidation of steroid modulators of GABA(A) receptors.

[1]  S. Mellon,et al.  Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Chetyrkin,et al.  Characterization of truncated mutants of human microsomal short-chain dehydrogenase/reductase RoDH-4. , 2003, Chemico-biological interactions.

[3]  J. Simard,et al.  17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. , 1999, Journal of molecular endocrinology.

[4]  A. Probst,et al.  Neuropathology and Genetics of Dementia , 2001, Advances in Experimental Medicine and Biology.

[5]  Yun Feng,et al.  Processing of proSAAS in neuroendocrine cell lines. , 2002, The Biochemical journal.

[6]  F. Holsboer,et al.  Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology , 2001, Brain Research Reviews.

[7]  N. Palackal,et al.  Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. , 2000, The Biochemical journal.

[8]  Song-Yu Yang,et al.  Function of human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase in androgen metabolism. , 2000, Biochimica et biophysica acta.

[9]  G. Biggio,et al.  Stress and neuroactive steroids. , 2001, International review of neurobiology.

[10]  R. Sharpe,et al.  Differentiation-dependent expression of 17beta-hydroxysteroid dehydrogenase, type 10, in the rodent testis: effect of aging in Leydig cells. , 2003, Endocrinology.

[11]  Song-Yu Yang,et al.  A Human Brain l-3-Hydroxyacyl-coenzyme A Dehydrogenase Is Identical to an Amyloid β-Peptide-binding Protein Involved in Alzheimer’s Disease* , 1998, The Journal of Biological Chemistry.

[12]  J. Wegiel,et al.  Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome , 2002, Acta Neuropathologica.

[13]  Athel Cornish-Bowden,et al.  Analysis of enzyme kinetic data , 1995 .

[14]  Song-Yu Yang,et al.  Characterization and localization of human type10 17β-hydroxysteroid dehydrogenase , 2001 .

[15]  J. Thyberg,et al.  Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: characterization of multifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD. , 2003, The Biochemical journal.

[16]  J. Trauger,et al.  Kinetics of allopregnanolone formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2). , 2002, Biochemistry.

[17]  K. Cheng,et al.  Substrate Specificity, Gene Structure, and Tissue-specific Distribution of Multiple Human 3α-Hydroxysteroid Dehydrogenases (*) , 1995, The Journal of Biological Chemistry.

[18]  Song-Yu Yang,et al.  Human Brain Short Chain l-3-Hydroxyacyl Coenzyme A Dehydrogenase Is a Single-domain Multifunctional Enzyme , 1999, The Journal of Biological Chemistry.

[19]  S. Mellon,et al.  Biosynthesis and action of neurosteroids , 2001, Brain Research Reviews.

[20]  R. Ivell,et al.  The gene for the Alzheimer-associated beta-amyloid-binding protein (ERAB) is differentially expressed in the testicular Leydig cells of the azoospermic by w/w(v) mouse. , 1998, European journal of biochemistry.

[21]  S. Paul,et al.  Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. , 1986, Science.

[22]  T. Penning,et al.  Molecular endocrinology of hydroxysteroid dehydrogenases. , 1997, Endocrine reviews.

[23]  D. Lin,et al.  Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model. , 2002, Brain research. Molecular brain research.

[24]  M. Banfield,et al.  Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD). , 2000, Journal of molecular biology.

[25]  A. Guidotti,et al.  Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Song-Yu Yang,et al.  Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase. , 2000, The Biochemical journal.

[27]  D. Peehl,et al.  Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. , 2003, Endocrinology.

[28]  J. A. Peters,et al.  Neurosteroids and GABAA receptor function. , 1995, Trends in pharmacological sciences.

[29]  D. Russell,et al.  Expression Cloning and Characterization of Oxidative 17β- and 3α-Hydroxysteroid Dehydrogenases from Rat and Human Prostate* , 1997, The Journal of Biological Chemistry.

[30]  M. Lewis,et al.  Structure–function relationships in 3α-hydroxysteroid dehydrogenases: a comparison of the rat and human isoforms , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[31]  S. Mellon,et al.  Neurosteroids: biochemistry and clinical significance , 2002, Trends in Endocrinology & Metabolism.

[32]  J. Adamski,et al.  A guide to 17β-hydroxysteroid dehydrogenases , 2001, Molecular and Cellular Endocrinology.

[33]  E. Baulieu,et al.  Neurosteroids: A new brain function? , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[34]  S. Chetyrkin,et al.  Characterization of a novel type of human microsomal 3alpha -hydroxysteroid dehydrogenase: unique tissue distribution and catalytic properties. , 2001, The Journal of biological chemistry.

[35]  S. Chetyrkin,et al.  Further Characterization of Human Microsomal 3α-Hydroxysteroid Dehydrogenase , 2001 .

[36]  S. Yang,et al.  Role of type 10 17beta-hydroxysteroid dehydrogenase in the pathogenesis of Alzheimer's disease. , 2001, Advances in experimental medicine and biology.

[37]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[38]  D. Lin,et al.  Molecular cloning, modeling, and localization of rat type 10 17β-hydroxysteroid dehydrogenase 1 Nucleotide sequences of cDNAs of rat and mouse type 10 17β-HSDs have been deposited in the GeneBank™/EBI Data Bank with accession number AF069770 and AF233685, respectively. 1 , 2001, Molecular and Cellular Endocrinology.

[39]  Song-Yu Yang,et al.  Oxidative 3α-hydroxysteroid dehydrogenase activity of human type 10 17β-hydroxysteroid dehydrogenase , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[40]  Dennis Dickson,et al.  Deposition of Alzheimer’s vascular amyloid-β is associated with decreased expression of brain l-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB) , 2001, Brain Research.